Akari Therapeutics Plc (AKTX)
0.3932
+0.04
(+12.02%)
USD |
NASDAQ |
Dec 10, 16:00
0.38
-0.01
(-3.36%)
After-Hours: 17:42
Akari Therapeutics Total Assets (Quarterly): 45.38M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 110.50M |
| Cellectis SA | 343.04M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 43.50M |
| Autolus Therapeutics Plc | 661.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.69M |
| Shareholders Equity (Quarterly) | 22.69M |
| Debt to Equity Ratio | 0.0933 |
| Current Ratio | 0.1892 |
| Net Debt Paydown Yield | -1.29% |